查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2108201

家用醫療診斷設備市場分析與預測（至2035年）：類型、產品類型、技術、組件、應用、最終用戶、功能、解決方案、使用模式

Home Medical Diagnostic Device Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, End User, Functionality, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球家用醫療診斷設備市場預計將從2025年的234億美元成長到2035年的408億美元，複合年成長率（CAGR）為5.7%。這一市場成長的主要驅動力是市場對分散式診斷和便利醫療解決方案的強勁結構性需求。慢性病盛行率的上升、對長期健康監測和早期檢測的日益重視以及數位醫療的普及，都在推動家用診斷技術的需求。此外，分散式醫療、遠端患者監護和自我檢測的趨勢也進一步促進了便捷易用的診斷解決方案的普及。

此市場細分為穿戴式裝置、手持裝置、行動裝置、智慧型手機裝置、試劑盒、試紙、測量儀器、感測器和其他形式，每種產品在便攜性、自動化程度、連接性和診斷複雜程度方面各不相同。穿戴式裝置和感測器可實現持續的生理功能監測，而手持和可攜式系統則支援現場測量和分散式檢查。由於其簡便性、經濟性和廣泛的可用性，試劑盒和試紙在快速自測中仍發揮重要作用。另一方面，測量儀器可提供血糖值和其他生物標記的定量測量。智慧型手機連接設備正擴大將硬體與行動應用程式、雲端連接和數據分析相結合。這種成長是由小型化、無線連接、人工智慧驅動的結果解讀以及消費者對便捷自測日益成長的需求所驅動的。

市場區隔
種類 血糖儀、血壓計、脈動式血氧監測儀系統、妊娠測試儀、不孕症檢測套組、膽固醇檢測套組、心電圖儀、體溫計、肺計量計等。
產品 穿戴式裝置、手持裝置、行動裝置、智慧型手機連接裝置、檢測套組、測量條、測量儀器、感測器等。
科技 生物感測器、微流體技術、晶片實驗室、人工智慧、藍牙連接、雲端運算、行動應用、遠端醫療等。
成分 感測器、顯示單元、電池、軟體、連接模組、資料儲存等。
目的 糖尿病管理、心血管監測、呼吸監測、懷孕和不孕症檢測、傳染病檢查、癌症篩檢、慢性病管理、健康狀況監測等。
最終用戶 居家照護、診所、醫院、診斷中心、門診部、長期照護機構、零售藥局、網路藥局等。
功能 即時監控、數據分析、遠端監控、警報和通知、數據共用、使用者介面等。
解決方案 整合平台、獨立設備、互聯生態系統等等。
實作方法 自測、專業測試、遠端測試等。

應用領域包括糖尿病管理、心血管監測、呼吸系統監測、懷孕和不孕症檢測、傳染病檢查、癌症篩檢、慢性病管理、健康狀況監測以及其他新興診斷應用。由於慢性病高發生且需要在臨床環境之外進行頻繁測量，糖尿病和心血管監測已成為成熟的需求領域。快速且方便的家用檢測套組正被用於妊娠、不孕症和傳染病檢查，而連網型設備和遠端患者管理正擴大用於呼吸系統和慢性病監測。健康狀況監測正透過可追蹤生命徵象和生理參數的消費級穿戴裝置而不斷擴展。未來的成長將受到預防醫學的普及、人口老化、分散式醫療模式以及與數位健康平台的整合的影響。

區域概覽

北美在家庭醫療診斷市場佔重要地位，這得益於其先進的醫療基礎設施、較高的消費者意識、完善的保險報銷體係以及對互聯醫療技術的積極應用。美國是該地區的主要需求國，血糖值儀、妊娠測試、穿戴式監測設備、脈搏血氧飽和度分析儀和其他自測技術在美國已廣泛應用。成熟的醫療設備製造生態系統以及對數位醫療、遠端患者監護和診斷技術創新的巨額投資正在推動產品商業化。美國食品藥物管理局(FDA) 的法律規範以及促進分散式醫療服務的政策支持產品開發，而人口老化和慢性病盛行率的上升則支撐了持續的需求。

隨著醫療保健服務可近性的提高、慢性病盛行率的上升以及消費者對價格合理的自我監測和快速檢測解決方案的需求日益成長，亞太地區有望迎來顯著成長。中國、日本、印度、韓國和澳洲是關鍵市場，這得益於不斷完善的醫療基礎設施、本土醫療設備製造業以及日益壯大的數位健康生態系統。遠端醫療、遠端監測、智慧型手機連接以及對本地診斷設備生產的投資，正在將醫療服務範圍擴展到醫院和檢查室之外。政府在預防醫學、基層醫療現代化和數位健康方面的舉措，正在推動這些技術的應用。不斷成長的醫療保健支出、龐大的患者群體、日益增強的健康意識以及對經濟高效診斷的需求，預計將進一步提升該地區的市場機會。

主要趨勢和促進因素

互聯醫療革命：智慧診斷走進家庭：

隨著製造商加快整合感測器、行動應用、雲端平台和人工智慧分析技術的步伐，家用診斷設備與互聯數位健康生態系統的融合正在重塑市場格局。互聯血糖監測、穿戴式生命徵象追蹤、基於智慧型手機的檢測以及遠端患者監護，能夠將數據持續傳輸給臨床醫生和看護者。這種融合正將家用診斷從孤立的自我監測轉變為長期健康管理，從而提高數據可及性，支持早期療育，並強化個人化照護的途徑。

慢性病病例激增，推動了家庭監測的需求：

全球慢性病負擔日益加重，是推動家庭醫療診斷設備需求成長的主要因素。這是因為患者越來越需要頻繁監測，而無需反覆前往醫院或檢測機構。糖尿病、心血管疾病、呼吸系統疾病和其他慢性病的增加，促使血糖值儀、血壓計、脈動式血氧監測儀系統、穿戴式感測器和連網監測系統廣泛應用。醫療服務提供者也正在推廣分散式醫療服務，以降低系統成本並提高病患參與度。此外，人口老化和對預防性健康管理日益成長的需求，也推動了家用診斷技術的持續應用。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 血糖值儀
    • 血壓監測儀
    • 脈搏血氧飽和度分析儀
    • 驗孕棒
    • 排卵和不孕症監測
    • 膽固醇檢測
    • 心電圖（ECG）測量設備
    • 溫度計
    • 肺計量計
    • 其他
  • 市場規模及預測：依產品分類
    • 穿戴式裝置
    • 手持裝置
    • 行動裝置
    • 基於智慧型手機的設備
    • 成套工具
    • 條狀物
    • 儀表
    • 感應器
    • 其他
  • 市場規模及預測：依技術分類
    • 生物感測器
    • 微流體技術
    • 晶片實驗室
    • 人工智慧
    • 藍牙連接
    • 雲端運算
    • 行動應用
    • 遠端照護
    • 其他
  • 市場規模及預測：依應用領域分類
    • 糖尿病管理
    • 心血管監測
    • 呼吸監測
    • 妊娠和不孕症檢查
    • 傳染病檢查
    • 癌症篩檢
    • 慢性病管理
    • 健康監測
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 居家醫療
    • 診所
    • 醫院
    • 診斷中心
    • 門診治療
    • 長期照護機構
    • 零售藥房
    • 網路藥房
    • 其他
  • 市場規模及預測：依組件分類
    • 感應器
    • 顯示器數量
    • 電池
    • 軟體
    • 連接模組
    • 資料閘道器
    • 其他
  • 市場規模及預測：功能
    • 即時監控
    • 數據分析
    • 遠端監控
    • 警報和通知
    • 數據共用
    • 使用者介面
    • 其他
  • 市場規模及預測：按模式
    • 自我診斷
    • 專業測試
    • 遠端測試
    • 其他
  • 市場規模及預測：按解決方案分類
    • 整合平台
    • 獨立設備
    • 互聯生態系統
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Johnson & Johnson
  • Thermo Fisher Scientific
  • Becton Dickinson
  • GE Healthcare
  • Philips Healthcare
  • Danaher Corporation
  • Medtronic
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Hologic
  • PerkinElmer
  • Qiagen
  • Alere
  • Sysmex Corporation
  • OraSure Technologies
  • Sekisui Diagnostics
  • Nova Biomedical

第9章 關於我們

簡介目錄
Product Code: GIS34834

The global Home Medical Diagnostic Device Market is projected to grow from $23.4 billion in 2025 to $40.8 billion by 2035, at a compound annual growth rate (CAGR) of 5.7%. The market is supported by strong structural demand for decentralized diagnostics and accessible healthcare solutions. Rising prevalence of chronic diseases, increasing emphasis on long-term health monitoring and early detection, and the expansion of digital health adoption are driving demand for home diagnostic technologies. The shift toward decentralized care, remote patient monitoring, and self-testing is further supporting the adoption of convenient and accessible diagnostic solutions.

The market is structured across wearable devices, handheld devices, portable devices, smartphone-based devices, kits, strips, meters, sensors, and other formats, reflecting varying levels of portability, automation, connectivity, and diagnostic complexity. Wearables and sensors enable continuous physiological monitoring, while handheld and portable systems support point-of-care measurements and decentralized testing. Kits and strips remain important for rapid, user-operated testing because of their simplicity, affordability, and broad availability, whereas meters provide quantitative measurements for glucose and other biomarkers. Smartphone-integrated devices increasingly combine hardware with mobile applications, cloud connectivity, and data analytics. Growth is supported by miniaturization, wireless connectivity, AI-enabled interpretation, and rising consumer demand for convenient self-monitoring.

Market Segmentation
TypeBlood Glucose Monitors, Blood Pressure Monitors, Pulse Oximeters, Pregnancy Tests, Fertility Monitors, Cholesterol Tests, ECG Devices, Thermometers, Spirometers, Others
ProductWearable Devices, Handheld Devices, Portable Devices, Smartphone-based Devices, Kits, Strips, Meters, Sensors, Others
TechnologyBiosensors, Microfluidics, Lab-on-a-chip, Artificial Intelligence, Bluetooth Connectivity, Cloud Computing, Mobile Applications, Telemedicine, Others
ComponentSensors, Display Units, Batteries, Software, Connectivity Modules, Data Storage, Others
ApplicationDiabetes Management, Cardiovascular Monitoring, Respiratory Monitoring, Pregnancy and Fertility Testing, Infectious Disease Testing, Cancer Screening, Chronic Disease Management, Wellness Monitoring, Others
End UserHome Care Settings, Clinics, Hospitals, Diagnostic Centers, Ambulatory Care, Long-term Care Facilities, Retail Pharmacies, Online Pharmacies, Others
FunctionalityReal-time Monitoring, Data Analysis, Remote Monitoring, Alerts and Notifications, Data Sharing, User Interface, Others
SolutionsIntegrated Platforms, Standalone Devices, Connected Ecosystems, Others
ModeSelf-testing, Professional Testing, Remote Testing, Others

Applications include diabetes management, cardiovascular monitoring, respiratory monitoring, pregnancy and fertility testing, infectious disease testing, cancer screening, chronic disease management, wellness monitoring, and other emerging diagnostic uses. Diabetes and cardiovascular monitoring represent established demand centers due to the prevalence of chronic conditions and the need for frequent measurements outside clinical settings. Pregnancy, fertility, and infectious disease testing benefit from rapid, accessible home-based kits, while respiratory and chronic disease monitoring increasingly leverage connected devices and remote patient management. Wellness monitoring is expanding through consumer wearables capable of tracking vital signs and physiological parameters. Future growth will be shaped by preventive healthcare adoption, aging populations, decentralized care models, and integration with digital health platforms.

Geographical Overview

North America maintains a substantial position in the home medical diagnostic device market, supported by advanced healthcare infrastructure, high consumer awareness, established reimbursement pathways, and strong adoption of connected medical technologies. The United States represents the region's principal demand base, with widespread use of glucose meters, pregnancy tests, wearable monitoring devices, pulse oximeters, and other self-testing technologies. A mature medical device manufacturing ecosystem and significant investment in digital health, remote patient monitoring, and diagnostic innovation reinforce commercialization. Regulatory oversight by the U.S. Food and Drug Administration and healthcare policies promoting decentralized care are supporting product development, while aging demographics and chronic disease prevalence sustain recurring demand.

Asia-Pacific presents substantial expansion potential as healthcare access improves, chronic disease prevalence rises, and consumers increasingly adopt affordable self-monitoring and rapid testing solutions. China, Japan, India, South Korea, and Australia are key markets, supported by expanding healthcare infrastructure, domestic medical device manufacturing, and growing digital health ecosystems. Investments in telemedicine, remote monitoring, smartphone connectivity, and local diagnostic production are broadening access beyond hospitals and laboratories. Government initiatives focused on preventive healthcare, primary care modernization, and digital health are encouraging adoption. Increasing healthcare expenditure, large patient populations, rising health awareness, and demand for cost-efficient diagnostics are expected to strengthen regional market opportunities.

Key Trends and Drivers

Connected Care Revolution: Smart Diagnostics Move Into the Home:

The integration of home diagnostic devices with connected digital health ecosystems is reshaping the market, as manufacturers increasingly combine sensors, mobile applications, cloud platforms, and AI-enabled analytics. Connected glucose monitoring, wearable vital-sign tracking, smartphone-based testing, and remote patient monitoring are enabling continuous data transmission to clinicians and caregivers. This convergence is shifting home diagnostics from isolated self-testing toward longitudinal health management, improving data accessibility, supporting earlier intervention, and strengthening personalized care pathways.

Chronic Disease Surge Fuels Demand for At-Home Monitoring:

The rising global burden of chronic diseases is a major demand catalyst for home medical diagnostic devices because patients increasingly require frequent monitoring without repeated hospital or laboratory visits. Growing diabetes, cardiovascular, respiratory, and other chronic conditions are encouraging adoption of glucose meters, blood pressure monitors, pulse oximeters, wearable sensors, and connected monitoring systems. Healthcare providers are also promoting decentralized care to reduce system costs and improve patient engagement, while aging populations and increasing demand for preventive health management further support recurring utilization of home-based diagnostic technologies.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Application
  • 2.5 Key Market Highlights by End User
  • 2.6 Key Market Highlights by Component
  • 2.7 Key Market Highlights by Functionality
  • 2.8 Key Market Highlights by Mode
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Blood Glucose Monitors
    • 4.1.2 Blood Pressure Monitors
    • 4.1.3 Pulse Oximeters
    • 4.1.4 Pregnancy Tests
    • 4.1.5 Fertility Monitors
    • 4.1.6 Cholesterol Tests
    • 4.1.7 ECG Devices
    • 4.1.8 Thermometers
    • 4.1.9 Spirometers
    • 4.1.10 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Wearable Devices
    • 4.2.2 Handheld Devices
    • 4.2.3 Portable Devices
    • 4.2.4 Smartphone-based Devices
    • 4.2.5 Kits
    • 4.2.6 Strips
    • 4.2.7 Meters
    • 4.2.8 Sensors
    • 4.2.9 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Biosensors
    • 4.3.2 Microfluidics
    • 4.3.3 Lab-on-a-chip
    • 4.3.4 Artificial Intelligence
    • 4.3.5 Bluetooth Connectivity
    • 4.3.6 Cloud Computing
    • 4.3.7 Mobile Applications
    • 4.3.8 Telemedicine
    • 4.3.9 Others
  • 4.4 Market Size & Forecast by Application (2020-2035)
    • 4.4.1 Diabetes Management
    • 4.4.2 Cardiovascular Monitoring
    • 4.4.3 Respiratory Monitoring
    • 4.4.4 Pregnancy and Fertility Testing
    • 4.4.5 Infectious Disease Testing
    • 4.4.6 Cancer Screening
    • 4.4.7 Chronic Disease Management
    • 4.4.8 Wellness Monitoring
    • 4.4.9 Others
  • 4.5 Market Size & Forecast by End User (2020-2035)
    • 4.5.1 Home Care Settings
    • 4.5.2 Clinics
    • 4.5.3 Hospitals
    • 4.5.4 Diagnostic Centers
    • 4.5.5 Ambulatory Care
    • 4.5.6 Long-term Care Facilities
    • 4.5.7 Retail Pharmacies
    • 4.5.8 Online Pharmacies
    • 4.5.9 Others
  • 4.6 Market Size & Forecast by Component (2020-2035)
    • 4.6.1 Sensors
    • 4.6.2 Display Units
    • 4.6.3 Batteries
    • 4.6.4 Software
    • 4.6.5 Connectivity Modules
    • 4.6.6 Data Storage
    • 4.6.7 Others
  • 4.7 Market Size & Forecast by Functionality (2020-2035)
    • 4.7.1 Real-time Monitoring
    • 4.7.2 Data Analysis
    • 4.7.3 Remote Monitoring
    • 4.7.4 Alerts and Notifications
    • 4.7.5 Data Sharing
    • 4.7.6 User Interface
    • 4.7.7 Others
  • 4.8 Market Size & Forecast by Mode (2020-2035)
    • 4.8.1 Self-testing
    • 4.8.2 Professional Testing
    • 4.8.3 Remote Testing
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Integrated Platforms
    • 4.9.2 Standalone Devices
    • 4.9.3 Connected Ecosystems
    • 4.9.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Application
      • 5.2.1.5 End User
      • 5.2.1.6 Component
      • 5.2.1.7 Functionality
      • 5.2.1.8 Mode
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Application
      • 5.2.2.5 End User
      • 5.2.2.6 Component
      • 5.2.2.7 Functionality
      • 5.2.2.8 Mode
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Application
      • 5.2.3.5 End User
      • 5.2.3.6 Component
      • 5.2.3.7 Functionality
      • 5.2.3.8 Mode
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Application
      • 5.3.1.5 End User
      • 5.3.1.6 Component
      • 5.3.1.7 Functionality
      • 5.3.1.8 Mode
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Application
      • 5.3.2.5 End User
      • 5.3.2.6 Component
      • 5.3.2.7 Functionality
      • 5.3.2.8 Mode
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Application
      • 5.3.3.5 End User
      • 5.3.3.6 Component
      • 5.3.3.7 Functionality
      • 5.3.3.8 Mode
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Application
      • 5.4.1.5 End User
      • 5.4.1.6 Component
      • 5.4.1.7 Functionality
      • 5.4.1.8 Mode
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Application
      • 5.4.2.5 End User
      • 5.4.2.6 Component
      • 5.4.2.7 Functionality
      • 5.4.2.8 Mode
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Application
      • 5.4.3.5 End User
      • 5.4.3.6 Component
      • 5.4.3.7 Functionality
      • 5.4.3.8 Mode
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Application
      • 5.4.4.5 End User
      • 5.4.4.6 Component
      • 5.4.4.7 Functionality
      • 5.4.4.8 Mode
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Application
      • 5.4.5.5 End User
      • 5.4.5.6 Component
      • 5.4.5.7 Functionality
      • 5.4.5.8 Mode
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Application
      • 5.4.6.5 End User
      • 5.4.6.6 Component
      • 5.4.6.7 Functionality
      • 5.4.6.8 Mode
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Application
      • 5.4.7.5 End User
      • 5.4.7.6 Component
      • 5.4.7.7 Functionality
      • 5.4.7.8 Mode
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Application
      • 5.5.1.5 End User
      • 5.5.1.6 Component
      • 5.5.1.7 Functionality
      • 5.5.1.8 Mode
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Application
      • 5.5.2.5 End User
      • 5.5.2.6 Component
      • 5.5.2.7 Functionality
      • 5.5.2.8 Mode
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Application
      • 5.5.3.5 End User
      • 5.5.3.6 Component
      • 5.5.3.7 Functionality
      • 5.5.3.8 Mode
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Application
      • 5.5.4.5 End User
      • 5.5.4.6 Component
      • 5.5.4.7 Functionality
      • 5.5.4.8 Mode
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Application
      • 5.5.5.5 End User
      • 5.5.5.6 Component
      • 5.5.5.7 Functionality
      • 5.5.5.8 Mode
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Application
      • 5.5.6.5 End User
      • 5.5.6.6 Component
      • 5.5.6.7 Functionality
      • 5.5.6.8 Mode
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Application
      • 5.6.1.5 End User
      • 5.6.1.6 Component
      • 5.6.1.7 Functionality
      • 5.6.1.8 Mode
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Application
      • 5.6.2.5 End User
      • 5.6.2.6 Component
      • 5.6.2.7 Functionality
      • 5.6.2.8 Mode
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Application
      • 5.6.3.5 End User
      • 5.6.3.6 Component
      • 5.6.3.7 Functionality
      • 5.6.3.8 Mode
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Application
      • 5.6.4.5 End User
      • 5.6.4.6 Component
      • 5.6.4.7 Functionality
      • 5.6.4.8 Mode
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Application
      • 5.6.5.5 End User
      • 5.6.5.6 Component
      • 5.6.5.7 Functionality
      • 5.6.5.8 Mode
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Roche Diagnostics
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Abbott Laboratories
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Siemens Healthineers
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Johnson & Johnson
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Thermo Fisher Scientific
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Becton Dickinson
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 GE Healthcare
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Philips Healthcare
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Danaher Corporation
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Medtronic
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Quidel Corporation
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Bio-Rad Laboratories
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Hologic
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 PerkinElmer
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Qiagen
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Alere
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Sysmex Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 OraSure Technologies
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Sekisui Diagnostics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Nova Biomedical
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us